- Report
- October 2022
- 70 Pages
Global
From €4372EUR$4,950USD£3,734GBP
- Report
- July 2022
- 54 Pages
Global
From €2164EUR$2,450USD£1,848GBP
- Report
- July 2022
- 137 Pages
Global
From €4372EUR$4,950USD£3,734GBP
From €4372EUR$4,950USD£3,734GBP
- Report
- February 2022
- 101 Pages
Global
From €4372EUR$4,950USD£3,734GBP
- Report
- January 2022
- 46 Pages
Global
From €2164EUR$2,450USD£1,848GBP
- Report
- October 2021
- 61 Pages
Global
From €4372EUR$4,950USD£3,734GBP
- Report
- September 2021
- 41 Pages
Global
- Report
- October 2020
- 98 Pages
Global
From €4372EUR$4,950USD£3,734GBP
- Report
- September 2020
- 45 Pages
North America
From €2605EUR$2,950USD£2,226GBP
- Report
- September 2020
- 80 Pages
Global
From €4372EUR$4,950USD£3,734GBP
- Report
- July 2020
- 39 Pages
Global
From €4372EUR$4,950USD£3,734GBP
- Report
- November 2019
- 271 Pages
Global
From €2650EUR$3,000USD£2,263GBP
- Report
- May 2019
- 75 Pages
United States
From €2650EUR$3,000USD£2,263GBP
From €5255EUR$5,950USD£4,489GBP
- Report
- February 2025
- 80 Pages
South Korea
From €3489EUR$3,950USD£2,980GBP
- Report
- November 2024
- 100 Pages
United Kingdom
From €5255EUR$5,950USD£4,489GBP
From €3489EUR$3,950USD£2,980GBP
- Report
- July 2024
- 150 Pages
Japan
From €5255EUR$5,950USD£4,489GBP
- Report
- June 2024
- 70 Pages
India
From €3489EUR$3,950USD£2,980GBP

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more